AKD—The Time Between AKI and CKD: What Is the Role of the Pharmacist?

Abstract

Get full access to this article

View all access options for this article.

References

Chawla

Bellomo

Bihorac

et al . Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13:241-257.

Coca

Singanamala

Parikh

. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442-448.

Pannu

James

Hemmelgarn

Klarenbach

. Alberta Kidney Disease Network. Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin J Am Soc Nephrol. 2013;8:194-202.

Menon

Kirkendall

Nguyen

Goldstein

. Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr. 2014;165(3):522-527.

Chaturvedi

Mammen

. The path to chronic kidney disease following acute kidney injury: a neonatal perspective. Pediatr Nephrol. 2017;32:227-241.

Silver

Siew

. Follow-up care in acute kidney injury: lost in transition. Adv Chronic Kidney Dis. 2017;24(4):246-252.

Coca

Yusuf

Shlipak

Garg

Parikh

. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961-973.

Harel

Wald

Bargman

et al . Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int. 2013;83:901-908.

Kirwan

BLuden

Dobbie

James

Nedungadi

Prowle

. Critically ill patients requiring acute renal replacement therapy are at an increased risk of long-term renal dysfunction, but rarely receive specialist nephrology follow-up. Nephron. 2015;129:164-170.

10.

Silver

Goldstein

Harel

et al . Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes. Can J Kidney Health Dis. 2015;2:36.

11.

Kielstein

Burkhardt

. Dosing of antibiotics in critically ill patients undergoing renal replacement therapy. Curr Pharm Biotechnol. 2011;12:2015-2019.

12.

Jang

Cerulli

Grabe

et al . NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011. Prev Chronic Dis. 2014;11:E220.

13.

Pai

. Keeping kidneys safe: the pharmacist’s role in NSAID avoidance in high-risk patients. J Am Pharm Assoc. 2015;55:e15-e23.

14.

Aspinall

Smith

Good

et al . Incremental cost effectiveness of pharmacist-managed erythropoiesis-stimulating agent clinics for non-dialysis-dependent chronic kidney disease patients. Appl Health Econ Health Policy. 2013;11:653-660.

15.

St Peter

Wazny

Patel

. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens. 2013;22(6):656-662.

16.

Narva

Romancito

Faber

Steele

Kempner

. Managing CKD by telemedicine: the Zuni Telenephrology Clinic. Adv Chronic Kidney Dis. 2017;24:6-11.

17.

Pourrat

Sipert

Gatault

et al . Community pharmacist intervention in patients with renal impairment. Int J Clin Pharm. 2015;37:1172-1179.

18.

Slevin

Talylor . Understanding what the public know about their kidneys and what they do. 2014. https://www.thinkkidneys.nhs.uk/wp-content/uploads/2015/01/Think-Kidneys-Report-Understanding-what-the-public-know-Jan-2015-11.pdf. Accessed August 28, 2017.

19.

Goldstein

Jaber

Faubel

Chawla

. Acute Kidney Injury Advisory Group of American Society of Nephrology. AKI transition of care: a potential opportunity to detect and prevent CKD. Clin J Am Soc Nephrol. 2013;8:476-483.

20.

Sarkar

Lopez

Maselli

Gonzales

. Adverse drug events in U.S. adult ambulatory medical care. Health Serv Res. 2011;46:1517-1533.

21.

Lipworth

Abdel-Kader

Morse

et al . High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study. BMC Nephrol. 2016;17:189.

22.

National Health Services England. When or if to re-start ACEI, ARB, diuretics and other antihypertensive drugs after an episode of acute kidney injury. https://www.thinkkidneys.nhs.uk/aki/wp-content/uploads/sites/2/2016/02/When-to-restart-drugs-stopped-during-AKI-final.pdf. Accessed August 28, 2017.

23.

Saran

Robinson

et al . US renal data system 2015 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2016;67:S1-305.

24.

Kane-Gill

Smithburger

Kashani

Kellum

Frazee

. Clinical relevance and predictive value of damage biomarkers of drug-induced kidney injury [published online ahead of print]. Drug Saf. 2017. doi:10.1007/s40264-017-0565-7

25.

Sutherland

Chawla

Kane-Gill

et al . Utilizing electronic health records to predict acute kidney injury risk and outcomes: workgroup statements from the 15(th) ADQI Consensus Conference. Can J Kidney Health Dis. 2016;3:11.